...
首页> 外文期刊>Pediatric Hematology Oncology Journal >High SVR in difficult to treat HCV infected Thalassemia major patients with DAA
【24h】

High SVR in difficult to treat HCV infected Thalassemia major patients with DAA

机译:高SVR难以治疗HCV感染的地中海贫血重症DAA患者

获取原文
           

摘要

: Dapsone is one of the second line treatments of immunethrombocytopenic purpura (ITP) with a response rate of about 50%.Dapsone Induced Agranulocytosis( DIA) is rare and life threatening idio-syncratic reaction associated with Dapsone therapy. High risk of DIA, he-molytic anemia(HA) & methemoglobinemia has been reported in leprosyand dermatitis herpitiformis patiens related to drug dosage or increasedimmunological responsiveness but there are no case reports of HA and lifethreatening DIA during the treatment of ITP. We report a case of agranu-locytosis induced septic shock due to dapsone. Through this case , weattempt to create the clinical awareness of its risks and highlight the needfor CBC monitoring of patients treated with Dapsone in order to favor earlytreatment of adverse effects.
机译::氨苯砜是免疫性血小板减少性紫癜(ITP)的二线治疗之一,其应答率约为50%。氨苯砜诱导的粒细胞缺乏症(DIA)很少见,并且与氨苯砜治疗相关的危及生命的特异体质反应。麻风和皮炎性疱疹患者中已报道了与药物剂量或免疫反应性增加相关的DIA,溶血性贫血(HA)和高铁血红蛋白血症的高风险,但尚无在ITP治疗期间发生HA和威胁生命的DIA的病例报道。我们报告一例由于氨苯砜引起的粒细胞缺乏症引起的败血性休克。通过这种情况,我们尝试建立对其风险的临床认识,并强调需要对氨苯砜治疗的患者进行CBC监测,以利于早期治疗不良反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号